RhumbLine Advisers’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-98,289
Closed -$2.35M 3205
2021
Q1
$2.35M Sell
98,289
-12,009
-11% -$287K ﹤0.01% 1840
2020
Q4
$1.61M Buy
110,298
+1,680
+2% +$24.5K ﹤0.01% 1947
2020
Q3
$1.54M Sell
108,618
-12,015
-10% -$171K ﹤0.01% 1817
2020
Q2
$1.78M Buy
120,633
+26,862
+29% +$395K ﹤0.01% 1797
2020
Q1
$386K Sell
93,771
-500
-0.5% -$2.06K ﹤0.01% 2281
2019
Q4
$453K Buy
94,271
+1,372
+1% +$6.59K ﹤0.01% 2410
2019
Q3
$563K Sell
92,899
-2,950
-3% -$17.9K ﹤0.01% 2269
2019
Q2
$622K Buy
95,849
+5,807
+6% +$37.7K ﹤0.01% 2269
2019
Q1
$638K Sell
90,042
-2,000
-2% -$14.2K ﹤0.01% 2222
2018
Q4
$447K Buy
92,042
+46,236
+101% +$225K ﹤0.01% 2348
2018
Q3
$337K Sell
45,806
-3,280
-7% -$24.1K ﹤0.01% 2463
2018
Q2
$313K Buy
49,086
+5,309
+12% +$33.9K ﹤0.01% 2508
2018
Q1
$238K Sell
43,777
-550
-1% -$2.99K ﹤0.01% 2543
2017
Q4
$185K Sell
44,327
-4,893
-10% -$20.4K ﹤0.01% 2653
2017
Q3
$474K Buy
49,220
+775
+2% +$7.46K ﹤0.01% 2335
2017
Q2
$573K Buy
48,445
+408
+0.8% +$4.83K ﹤0.01% 2230
2017
Q1
$616K Buy
48,037
+2,321
+5% +$29.8K ﹤0.01% 2160
2016
Q4
$560K Sell
45,716
-1,482
-3% -$18.2K ﹤0.01% 2165
2016
Q3
$557K Buy
47,198
+900
+2% +$10.6K ﹤0.01% 2132
2016
Q2
$403K Buy
46,298
+4,849
+12% +$42.2K ﹤0.01% 2345
2016
Q1
$218K Buy
41,449
+650
+2% +$3.42K ﹤0.01% 2699
2015
Q4
$317K Buy
40,799
+3,490
+9% +$27.1K ﹤0.01% 2544
2015
Q3
$294K Buy
37,309
+1,429
+4% +$11.3K ﹤0.01% 2557
2015
Q2
$325K Sell
35,880
-3,135
-8% -$28.4K ﹤0.01% 2606
2015
Q1
$506K Buy
39,015
+6,725
+21% +$87.2K ﹤0.01% 2294
2014
Q4
$439K Buy
32,290
+1,000
+3% +$13.6K ﹤0.01% 2346
2014
Q3
$281K Hold
31,290
﹤0.01% 2562
2014
Q2
$423K Buy
31,290
+5,598
+22% +$75.7K ﹤0.01% 2378
2014
Q1
$255K Sell
25,692
-1,420
-5% -$14.1K ﹤0.01% 2635
2013
Q4
$361K Buy
27,112
+1,300
+5% +$17.3K ﹤0.01% 2461
2013
Q3
$314K Buy
25,812
+282
+1% +$3.43K ﹤0.01% 2499
2013
Q2
$264K Buy
+25,530
New +$264K ﹤0.01% 2759